Report

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Expert Market Research Thumbnail Image

Global Cancer Therapeutics Market: By Top Selling Drugs: Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar; By Application: Blood cancer, Lung cancer, Breast cancer, Colorectal cancer, Prostate cancer, Cervical cancer, Head & neck cancer, Glioblastoma, Malignant meningioma, Mesothelioma, Melanoma; By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa; Historical Production and Consumption (2015-2019); Production and Consumption Forecast (2020-2025); SWOT Analysis; Porter’s Five Forces Analysis; Competitive Landscape & Supplier Analysis; Procurement Strategy; Trade Data Analysis; Cost Analysis and Project Economics

Global Cancer Therapeutics Market Key Insights:

 

  • Market Overview
  • Market Opportunities
  • Breakup by Region
  • Historical Market Size 2015-2019
  • Competitive Landscape
  • SWOT Analysis
  • Market Forecast 2020-2025
  • Events and Developments
  • Breakup by Application

 

Market Outlook

The global cancer therapeutics market stood at a value of USD 109,268.7 million in 2019 and is expected to achieve USD 194,634.5 million by 2025, recording a CAGR of 10.1% between 2020 and 2025. The cancer therapeutics market is being driven by the increased investment by companies in the R&D sector. The increasing incidences of cancer across the globe are also adding to the cancer therapeutics market growth.

Global Cancer Therapeutics Market Report and Forecast 2020-2025

Get a Free Sample Report with Table of Content - Download Now

Properties and Applications

Cancer therapy includes the use and administration of chemotherapy and oncology drugs for the treatment of cancer. It is a type of treatment that identifies and attacks particular kinds of cancer cells with less damage to ordinary cells with the help of drugs or other substances. Some targeted therapies block certain enzymes, proteins, or other molecules that are engaged in cancer cell development.

The cancer therapeutics market can be divided on the basis of segments like application and top-selling drugs. The industry can be broadly categorised based on its application into:

  • Blood cancer
  • Lung cancer
  • Breast cancer
  • Colorectal cancer
  • Prostate cancer
  • Cervical cancer
  • Head and neck cancer
  • Glioblastoma
  • Malignant Meningioma
  • Mesothelioma
  • Melanoma
  • Others

The cancer therapeutics market can be divided on the basis of its top-selling drugs as Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, and Temodar, among others.

The EMR report looks into the regional cancer therapeutics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

Market Analysis

An increase in the incidences of cancer, rising cooperation among pharmaceutical companies, and growing innovation in the cancer-research sector are factors that are driving the growth of the cancer therapeutics industry. It is anticipated that the geriatric population will increase over the forecast period, further increasing the demand for cancer therapy. Further, the rising demand for personalised medicine and increased investment in the healthcare sector, particularly in developing countries, is providing the cancer therapeutics market with new growth opportunities. Some of the factors that restrict cancer therapeutics market growth are high costs connected with oncology drug development and adverse effects associated with cancer therapy.

Competitive Landscape

The report presents a detailed analysis of the following key players in the global cancer therapeutics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • AbbVie Inc. (NYSE: ABBV)
  • Astellas Pharma Inc. 
  • Bristol Myers Squibb Company 
  • Celgene Corporation
  • F. Hoffmann-La Roche Ltd. 
  • Johnson & Johnson 
  • Merck & Co., Inc. 
  • Novartis AG 
  • Pfizer Inc. 
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.

Key Questions Answered in the Report:

  • How has the global cancer therapeutics market performed in the previous years (2015-2019)?
  • What is the forecasted assessment of the cancer therapeutics market for 2020-2025?
  • What are the major drivers for the historical (2015-2019) and forecast (2020-2025) periods?
  • What are the major constraints for the historical (2015-2019) and forecast (2020-2025) periods?
  • What are the major demand indicators of the global cancer therapeutics market?
  • What is the degree of competition in the global cancer therapeutics market?
  • What are the major events and developments taking place within the industry globally?

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Cost Structure
    4.5    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraint Analysis
    5.3    Industry Challenges
    5.4    Industry Opportunities
6     Global Cancer Therapeutics Market Analysis
    6.1     Global Cancer Therapeutics Historical Market (2015-2019) & Forecast (2020-2025)
    6.2     Global Cancer Therapeutics Market Breakup by Top Selling Drugs
        6.2.1    Revlimid
        6.2.2    Avastin
        6.2.3    Herceptin
        6.2.4    Rituxan
        6.2.5    Opdivo
        6.2.6    Gleevec
        6.2.7    Velcade
        6.2.8    Imbruvica
        6.2.9    Ibrance
        6.2.10    Zytiga
        6.2.11    Alimta
        6.2.12    Xtandi
        6.2.13    Tarceva
        6.2.14    Perjeta
        6.2.15    Temodar
        6.2.16    Others
    6.3     Global Cancer Therapeutics Market Breakup by Top Selling Drugs: Historical Market (2015-2019) & Forecast (2020-2025)
        6.3.1    Revlimid
        6.3.2    Avastin
        6.3.3    Herceptin
        6.3.4    Rituxan
        6.3.5    Opdivo
        6.3.6    Gleevec
        6.3.7    Velcade
        6.3.8    Imbruvica
        6.3.9    Ibrance
        6.3.10    Zytiga
        6.3.11    Alimta
        6.3.12    Xtandi
        6.3.13    Tarceva
        6.3.14    Perjeta
        6.3.15    Temodar
        6.3.16    Others
    6.4     Global Cancer Therapeutics Market by Application
        6.4.1    Blood Cancer
        6.4.2    Lung Cancer
        6.4.3    Breast Cancer
        6.4.4    Colorectal Cancer
        6.4.5    Prostate Cancer
        6.4.6    Cervical Cancer
        6.4.7    Head & Neck Cancer
        6.4.8    Glioblastoma
        6.4.9    Malignant Meningioma
        6.4.10    Mesothelioma
        6.4.11    Melanoma
        6.4.12    Others
    6.5     Global Cancer Therapeutics Market by Application: Historical Market (2015-2019) & Forecast (2020-2025)
        6.5.1    Blood Cancer
        6.5.2    Lung Cancer
        6.5.3    Breast Cancer
        6.5.4    Colorectal Cancer
        6.5.5    Prostate Cancer
        6.5.6    Cervical Cancer
        6.5.7    Head & Neck Cancer
        6.5.8    Glioblastoma
        6.5.9    Malignant Meningioma
        6.5.10    Mesothelioma
        6.5.11    Melanoma
        6.5.12    Others
    6.6     Global Cancer Therapeutics Market Breakup by Region
        6.6.1    North America
            6.6.1.1    United States of America
            6.6.1.2    Canada
        6.6.2    Europe
            6.6.2.1    Germany
            6.6.2.2    United Kingdom
            6.6.2.3    France
            6.6.2.4    Italy
            6.6.2.5    Others
        6.6.3    Asia Pacific
            6.6.3.1    China
            6.6.3.2    Japan
            6.6.3.3    India
            6.6.3.4    ASEAN
            6.6.3.5    Others
        6.6.4    Latin America
            6.6.4.1    Brazil
            6.6.4.2    Argentina
            6.6.4.3    Mexico
            6.6.4.4    Others
        6.6.5    Middle East & Africa
            6.6.5.1    Saudi Arabia
            6.6.5.2    United Arab Emirates
            6.6.5.3    Nigeria
            6.6.5.4    South Africa
            6.6.5.5    Others
    6.7     Global Cancer Therapeutics Breakup by Region: Historical Market (2015-2019) & Forecast (2020-2025)
        6.7.1    North America
            6.7.1.1    United States of America
            6.7.1.2    Canada
        6.7.2    Europe
            6.7.2.1    Germany
            6.7.2.2    United Kingdom
            6.7.2.3    France
            6.7.2.4    Italy
            6.7.2.5    Others
        6.7.3    Asia Pacific
            6.7.3.1    China
            6.7.3.2    Japan
            6.7.3.3    India
            6.7.3.4    ASEAN
            6.7.3.5    Others
        6.7.4    Latin America
            6.7.4.1    Brazil
            6.7.4.2    Argentina
            6.7.4.3    Mexico
            6.7.4.4    Others
        6.7.5    Middle East & Africa
            6.7.5.1    Saudi Arabia
            6.7.5.2    United Arab Emirates
            6.7.5.3    Nigeria
            6.7.5.4    South Africa
            6.7.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    Competitive Landscape & Supplier Analysis 
    9.1    AbbVie Inc. [ABBV (NYSE)]
        9.1.1    Company Overview
        9.1.2    Financial Analysis
    9.2    Astellas Pharma Inc. [4503 (TYO)]
        9.2.1    Company Overview
        9.2.2    Financial Analysis
    9.3    Bristol Myers Squibb Company [BMY (NYSE)]
        9.3.1    Company Overview
        9.3.2    Financial Analysis
    9.4    Celgene Corporation [CELG (NASDAQ)]
        9.4.1    Company Overview
        9.4.2    Financial Analysis
    9.5    F. Hoffmann-La Roche Ltd. [ROG (SWX)]
        9.5.1    Company Overview
        9.5.2    Financial Analysis
    9.6    Johnson & Johnson [JNJ (NYSE)]
        9.6.1    Company Overview
        9.6.2    Financial Analysis
    9.7    Merck & Co., Inc. [MRK (NYSE)]
        9.7.1    Company Overview
        9.7.2    Financial Analysis
    9.8    Novartis AG [NOVN (SWX)]
        9.8.1    Company Overview
        9.8.2    Financial Analysis
    9.9    Pfizer Inc. [PFE (NYSE)]
        9.9.1    Company Overview
        9.9.2    Financial Analysis
    9.10    Others
10    Events and Developments

Additional Customisation Available:

11    Feedstock Analysis
12    Procurement Strategy

    12.1    Value Chain Analysis
    12.2    Contract Terms
    12.3    Buying and Sourcing Trends
    12.4    Storage and Warehousing
    12.5    Certifications and Regulations
    12.6    Risk Factors
13    Trade Data Analysis
    13.1    Major Exporting Countries: By Value and Volume
    13.2    Major Importing Countries: By Value and Volume
14    Manufacturing Process
    14.1    Detailed Process Flow
    14.2    Operations Involved
    14.3    Mass Balance
15    Cost Analysis and Project Economics
    15.1    Land, Location and Site Development
    15.2    Construction
    15.3    Plant Machinery
    15.4    Cost of Raw Material
    15.5    Packaging
    15.6    Transportation
    15.7    Utilities
    15.8    Manpower
    15.9    Other Capital Investment
16    Production Cost Analysis

Introduction

EMR is one of the foremost business intelligence and market research firms with a database of syndicated and customised reports spanning more than 100 industries across global and regional markets. We leverage the knowledge of our highly skilled team of over 100 analysts and more than 3000 independent consultants to provide our clients with thoroughly researched and reliable data tailored to their requirements. We help our clients, who range from Fortune 1000 companies to medium and niche enterprises, make informed strategic decisions through our varied tools and methodology.

Our meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. We understand the distinct nature and requirements for each market and thus, modify our methodology to best fit the industry in question. Our research methodology uses a combination of cutting-edge analytical tools and the expertise of our highly accomplished team, thus, providing our customers with market insights that are accurate, actionable, and help them remain ahead of their competition. EMR’ s fine-tuned research methodology and data analysis, formulated through years of cross-industry experience of our team, ensure that our clients are provided with:

  • Value-added and infallible market intelligence.
  • A holistic understanding of the current and expected market fluctuations through meticulously collected data.
  • Verified information on the probable opportunities and risks in the present and forecasted markets.
  • Validated and thoroughly analysed insights derived from our latest analytical tools and impeccable sources.

Assessment Approach

Our approach gives our clients a comprehensive assessment of the prevailing and projected market conditions through the collection, collation, and analysis of data from trusted sources.

Price Assessment

We assess the historical, prevailing, and expected prices of commodities and raw materials by analysing our assiduously collected data from verified primary and secondary sources. Our assessments reflect the market values of related commodities within a region to help our consumers understand the interdependencies and formulate profitable market strategies. Our price assessments cover both the average global prices along with the prevailing regional prices.

Market Assessment

Our market assessments determine the global and regional production and consumption of the product, according to their value and volume. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future market growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions. We also take into account the demographic, economic, cultural, and political factors that might influence the market.

Data Collection

We gather market intelligence through our extensive database of reliable secondary sources and our exhaustive interviews with multiple industry stakeholders. The information gathered through our primary and secondary sources help us verify and extrapolate data relating to prices, trade, and market fluctuations along with the latest developments in the market.

Primary Research

As a part of our primary research, we interact with highly placed industrial professionals possessing an expansive and meticulous insight into the market. We conduct our interviews via mails, telephonic conversations, and one-on-one meetings. Thus, our exhaustive interviews with both buyers and consumers help us provide our clients with verified intelligence regarding the market size, share, drivers, prices, and forecast along with a detailed assessment of your supply chain.

Secondary Research

EMR has access to extensive internal and subscribed databases, which apprise us of the historical and prevailing market conditions and help us forecast the market for the coming few years. Our secondary research involves a wide array of sources ranging from the annual and financial reports of the key players in the industry to governmental and regulatory databases. We refer to various scientific and industry publications and whitepapers to form a comprehensive understanding of the product and the supply chain. Our wide-ranging research also refers to relevant articles and press releases to provide our customers with an up-to-date understanding of the contemporary market. We derive extensive raw data from our secondary research, which then go through a thorough verification and validation process, to help us formulate an exhaustive understanding of the market, the supply chain, the competitive landscape, and the product.

Other Analyst Tools and Data Models

Our extensive and intricate data models, formulated through our propriety technological and analytical resources, help you easily comprehend the expansive market data and aid you in framing vital business and market strategies. Our tools provide you with a cohesive understanding of the industry outlook, taking into account the qualitative and quantitative market variables. Our analytical tools and models are regularly updated according to the changes in the continually evolving market scenarios as well as being adapted to best meet our client’s specific needs. Our research methods involve a blend of the best technological tools used in the industry along with the expertise of our analysts and consultants who can spot and assess the implications of the subtle factors influencing the more complex markets.

Data Prioritisation

Our market assessments take into consideration only those data that are confirmed and are derived from credible and transparent sources. Thus, our clients are presented with accurate and infallible data which can be incorporated into their business strategies.

Data Validation

Before our data is presented to the clients, they undergo an intensive cross-verification and validation process. We corroborate the data gathered through our primary and secondary research by the review and validation of the initial sources along with the verification of the data from other thoroughly vetted sources.

Exigent Data Assessment

Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions. By constantly updating our databases and reports to reflect the changes taking place in the market, our market and price assessments accurately reflect the prevailing industry conditions.

Thus, our rigorous data collection, thorough statistical analysis, and specialist assessments ensure that our clientele has a greater understanding of the market space, supply chain, price fluctuations, competitive landscape, and other vital factors, helping them emerge as the undisputed industry leaders in their respective fields.

Purchase Options  

Buy Now  

Call us on

( USA & Canada )
+1-415-325-5166
us.sales@expertmarket
research.com
( United Kingdom )
+44-702-402-5790
uk.sales@expertmarket
research.com
Send Enquiry  

Purchase Full Report

  • Single User License
  • $2999
  • Restricted to one user
  • One print only
  • Available in PDF
  • Free limited customisation (pre sales)
  • Post sales analyst support
  • Free report update (Within 180 Days)
  • Buy Now
  • Five User License
  • $3999
  • Restricted to five users
  • One print per user
  • Available in PDF
  • Free limited customisation (pre sales)
  • Post sales analyst support
  • Free report update (Within 180 Days)
  • Buy Now
  • Corporate License
  • $4999
  • Unlimited users within organisation
  • No limit on prints
  • Available in PPT and PDF
  • Free limited customisation (pre sales)
  • Post sales analyst support
  • Free report update (Within 180 Days)
  • Buy Now

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Expert Market Research Thumbnail Image
Global Thoracic Surgery Market Report and Forecast 2020-2025

A thoracic surgery involves any chest organ treatment or operation including the heart, lungs, oesophagus, as well as trachea. Thoracic surgery is also recognised as chest surgery. Thoracic surgery is...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Stretch Marks Treatment Market Report and Forecast 2020-2025

The global stretch marks treatment market is driven by the growing incidences of stretch marks across the globe. Further, the rising prevalence of obesity owing to the increasing fast food and changin...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Primary Biliary Cholangitis Therapeutics Market Report and Forecast 2020-2025

Primary biliary cholangitis refers to a rare chronic disease of the liver, formerly referred to as primary biliary cirrhosis, mainly characterized by the degradation of the biliary ducts, which contai...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Upper Respiratory Tract Infection Treatment Market Report and Forecast 2020-2025

An upper respiratory tract infection (URTI) is an illness, which is the result of an acute infection involving a person’s upper respiratory tract like the nose, sinuses, pharynx, or larynx. The infe...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Unicompartmental Knee Prostheses Market Report and Forecast 2020-2025

The global unicompartmental knee prostheses market is estimated to grow at a CAGR of almost 3.8% in the forecast period of 2020-2025. The global unicompartmental knee prostheses market is being driven...

  • 24 Hour Email Delivery
  • Price: $ 2999

Stay informed with our free industry updates.

Download Sample

Buy Full Version
"Cancer Therapeutics Market" Purchase Enquiry